NCT02564016

Brief Summary

The goal of this study is to evaluate the effect of continuous postpartum epidural saline infusion on the reactivation of labor epidurals for postpartum tubal ligation surgery following vaginal delivery.

Trial Health

57
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
36

participants targeted

Target at below P25 for not_applicable pregnancy

Timeline
Completed

Started Oct 2014

Geographic Reach
1 country

1 active site

Status
terminated

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

October 1, 2014

Completed
10 months until next milestone

First Submitted

Initial submission to the registry

July 17, 2015

Completed
3 months until next milestone

First Posted

Study publicly available on registry

September 30, 2015

Completed
11 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

September 1, 2016

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

September 1, 2016

Completed
2.2 years until next milestone

Results Posted

Study results publicly available

November 14, 2018

Completed
Last Updated

November 14, 2018

Status Verified

October 1, 2018

Enrollment Period

1.9 years

First QC Date

July 17, 2015

Results QC Date

June 19, 2018

Last Update Submit

October 19, 2018

Conditions

Outcome Measures

Primary Outcomes (1)

  • Number of Participants With Successful Epidural Reactivation

    The goal of this study is to evaluate the effect of continuous postpartum epidural saline infusion on the reactivation of labor epidurals for postpartum tubal ligation surgery following vaginal delivery.

    one year

Secondary Outcomes (2)

  • Count of Participants Whose BMI Affected the Reactivation Rate of Labor Epidurals for Postpartum Tubal Ligation Surgery Following Vaginal Delivery.

    one year

  • Count of Participants Who Experienced Epidural Reactivation Failure

    one year

Study Arms (2)

Capped Epidural

ACTIVE COMPARATOR

Group 1 (control) will have the epidural catheter capped and left in place.

Other: Capped Epidural

Normal Saline Infusion

EXPERIMENTAL

Group 2 (treatment) will have an epidural infusion initiated with preservative-free normal saline at a continuous rate of 4ml/hour

Drug: Normal Saline Infusion

Interventions

Group 2 (treatment) will have an epidural infusion initiated with preservative-free normal saline at a continuous rate of 4ml/hour

Also known as: 0.9% Sodium Chloride
Normal Saline Infusion

epidural will be capped with no saline infusion.

Capped Epidural

Eligibility Criteria

Age18 Years+
Sexfemale
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Pregnant women
  • to 45 years of age
  • Admitted to MUSC in labor or for induction of labor resulting in a vaginal delivery epidural analgesia
  • Postpartum tubal ligation following delivery
  • American Society of Anesthesiologists (ASA) Physical Class 1, 2, and 3

You may not qualify if:

  • Critically Ill Patients (patients admitted to the ICU)
  • Cognitively Impaired Persons (patients with a diagnosis of cognitive deficit)
  • Cesarean delivery
  • Punctured dura
  • Patients enrolled in other epidural research studies

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Medical University of South Carolina

Charleston, South Carolina, 29425, United States

Location

MeSH Terms

Interventions

Sodium Chloride

Intervention Hierarchy (Ancestors)

ChloridesHydrochloric AcidChlorine CompoundsInorganic ChemicalsSodium Compounds

Results Point of Contact

Title
Laura L Roberts MD, Assistant Professor
Organization
Medical University of South Carolina

Study Officials

  • Laura Roberts, MD

    Medical University of South Carolina

    PRINCIPAL INVESTIGATOR

Publication Agreements

PI is Sponsor Employee
Yes
Restrictive Agreement
No

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

July 17, 2015

First Posted

September 30, 2015

Study Start

October 1, 2014

Primary Completion

September 1, 2016

Study Completion

September 1, 2016

Last Updated

November 14, 2018

Results First Posted

November 14, 2018

Record last verified: 2018-10

Locations